Are Milder IVF Methods the Way Forward?
By Ruth Wood,
The Telegraph
| 08. 03. 2015
[UK]
Crystal the chihuahua is a reminder to Mandy Bond of how she almost gave up on becoming a mother. She and her husband Tim bought the little dog to help ease the pain of spending £43,000 on four rounds of fertility treatment at two different clinics, without success. At the age of 40, with her expectations at rock bottom, Mrs Bond gave it one last shot at a third clinic specialising in “natural” IVF, in which doctors use no or very low doses of fertility drugs.
“I’ll never forget the phone call from the clinic nurse two weeks after I’d had the treatment,” said the 44-year-old who lives near Bristol. “The nurse said 'guess what?’ and I knew then that I was pregnant. I started laughing, then I started crying and then I started laughing again. I rushed upstairs to tell Tim. He just couldn’t compute that it had finally worked.”
Taylor was born the following spring, weighing 6lb 6oz, and has just celebrated his third birthday. He is one of more than five million people worldwide born through IVF...
Related Articles
By Grace Won, KQED [with CGS' Katie Hasson] | 12.02.2025
In the U.S., it’s illegal to edit genes in human embryos with the intention of creating a genetically engineered baby. But according to the Wall Street Journal, Bay Area startups are focused on just that. It wouldn’t be the first...
Several recent Biopolitical Times posts (1, 2, 3, 4) have called attention to the alarmingly rapid commercialization of “designer baby” technologies: polygenic embryo screening (especially its use to purportedly screen for traits like intelligence), in vitro gametogenesis (lab-made eggs and sperm), and heritable genome editing (also termed embryo editing or reproductive gene editing). Those three, together with artificial wombs, have been dubbed the “Gattaca stack” by Brian Armstrong, CEO of the cryptocurrency company...
By Lucy Tu, The Guardian | 11.05.2025
Beth Schafer lay in a hospital bed, bracing for the birth of her son. The first contractions rippled through her body before she felt remotely ready. She knew, with a mother’s pit-of-the-stomach intuition, that her baby was not ready either...
By Emily Glazer, Katherine Long, Amy Dockser Marcus, The Wall Street Journal | 11.08.2025
For months, a small company in San Francisco has been pursuing a secretive project: the birth of a genetically engineered baby.
Backed by OpenAI chief executive Sam Altman and his husband, along with Coinbase co-founder and CEO Brian Armstrong, the startup—called...